BNTX Insider Trading Activity and SEC Form 4 Filings
BNTX insider trading summary
Over the past 12 months, insiders at BioNTech SE (BNTX) reported 25 sales worth $82.6M by 2 insiders and no open-market purchases on SEC Form 4. Net insider selling was $82.6M.
Latest BNTX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Oct 9, 2026 | Ugur Sahin | Chief Executive Officer | Sell | $3.5M (36,209 @ $95.37) |
| Oct 8, 2026 | Ugur Sahin | Chief Executive Officer | Sell | $2.5M (27,000 @ $92.31) |
| Oct 7, 2026 | Ugur Sahin | Chief Executive Officer | Sell | $2.3M (24,000 @ $95.86) |
| Oct 6, 2026 | Ugur Sahin | Chief Executive Officer | Sell | $2.0M (21,000 @ $96.81) |
| Oct 5, 2026 | Ugur Sahin | Chief Executive Officer | Sell | $7.0M (72,000 @ $97.23) |
| Oct 2, 2026 | Ugur Sahin | Chief Executive Officer | Sell | $1.6M (17,000 @ $96.72) |
| Oct 1, 2026 | Ugur Sahin | Chief Executive Officer | Sell | $1.7M (17,000 @ $97.46) |
| Sep 30, 2026 | Ugur Sahin | Chief Executive Officer | Sell | $3.1M (32,000 @ $98.12) |
| Sep 29, 2026 | Ugur Sahin | Chief Executive Officer | Sell | $3.3M (34,000 @ $98.26) |
| Sep 28, 2026 | Ugur Sahin | Chief Executive Officer | Sell | $3.3M (34,000 @ $98.47) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.